![]() |
|
Case Report
| ||||||
| Secondary breast cancer after treatment for Hodgkin’s disease: A clinical case | ||||||
| Loubna Belhajjam1, Zineb Alami1, Asmaa Kouadir1, Abderahmane Elmazgh2, Touria Bouhafa2, Khalid Hassouni3 | ||||||
|
1Resident Doctor, Department of Radiotherapy Hassan II University Hospital, Faculty of Medecine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University, Fez, Morocco
2Associate Professor, Department of Radiotherapy Hassan II University Hospital, Faculty of Medecine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University, Fez, Morocco 3Professor and Head of the Department, Department of Rdiotherapy Hassan University Hospital, Faculty of Medecine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University, Fez, Morocco | ||||||
| ||||||
|
[HTML Full Text]
[PDF Full Text]
[Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar] |
| How to cite this article: |
| Belhajjam L, Alami Z, Kouadir A, Elmazghi A, Bouhafa T, Hassouni K. Secondary breast cancer after treatment for Hodgkin’s disease: A clinical case. J Case Rep Images Oncology 2017;3:39–43. |
|
ABSTRACT
|
|
Introduction:
Improved survival of patients treated for Hodgkin’s disease has been increased at the cost of late complications, the most frequent of which are secondary neoplasias such as breast cancers, which account for 6–9% of these neoplasias after treatment for MDH. The most favorable factors are mainly young age and radiotherapy.
Case Report: We report the observation of a patient treated for Hodgkin’s disease at the age of 17 years and after 17 years, she was diagnosed with right breast cancer, triple negative and then benefiting from breast-conserving surgery treatment and adjuvant chemotherapy and radiotherapy. Conclusion: We represent a general review of the risk factors and diagnostic, prognostic and therapeutic choices modulated according to the treatment received for the Hodgkin’s disease of these secondary mammary cancers. Survivors of Hodgkin’s disease may have a long life expectancy nowadays and it is important to develop appropriate methods for estimating the risk of late breast cancer. | |
|
Keywords:
Hodgkin’s disease, Radio induced neoplasms, Radiotherapy, Secondary breast cancer
| |
|
[HTML Full Text]
[PDF Full Text]
|
|
Author Contributions
Loubna Belhajjam – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Zineb Alami – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Asmaa Kouadir – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Abderahmane Elmazghi – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Touria Bouhafa – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Khalid Hassouni – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published |
|
Guarantor of submission
The corresponding author is the guarantor of submission. |
|
Source of support
None |
|
Conflict of interest
Authors declare no conflict of interest. |
|
Copyright
© 2017 Loubna Belhajjam et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information. |